Evaluation of Clinical and Quality of Life Effects of Oral Semaglutide Use in Type 2 Diabetes from a Public Health View: A Prospective Study in Italy

<b>Background and Aim:</b> Type 2 diabetes (T2D) continues to pose a significant public health challenge worldwide. Among therapeutic options, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have proven effective in optimizing glycemic control and improving cardiometabolic profiles. Semaglutid...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Paola Pantanetti, Vanessa Ronconi, Stefano Mancin, Cristina De Carolis, Sara Alberti, Orietta Pazzi, Sandra Di Marco, Grazia Michetti, Silvia Coacci, Veronica Mignini, Franco Gregorio, Giulia Baldoni, Sara Toderi, Sara Morales Palomares, Fabio Petrelli, Gabriele Caggianelli, Mauro Parozzi, Giovanni Cangelosi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-08-01
Serie:	Diabetology
Soggetti:	oral semaglutide type 2 diabetes quality of life prospective cohort study public health
Accesso online:	https://www.mdpi.com/2673-4540/6/8/80
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!